GELS logo

GELSGelteq Ltd.

$0.99
$0.54
(35.29%)
Today
Closed $0.99
$0.0201
(2.03%)
After Hours
Updated: 07:59 PM EDT
Mkt Cap$10.6M
Vol6.18M
News
all
press releases
What's Going On With Gelteq Stock Friday?
Micro-cap biotechnology stock Gelteq (GELS) faces erratic price swings, pulling back after a 200% spike. Stock down 33%.read more...
Benzinga
News Placeholder
More News
News Placeholder
Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion into China
Press Releases
News Placeholder
Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform
Press Releases
News Placeholder
Gelteq to Present at Investor Summit Virtual on December 9, 2025
Press Releases
News Placeholder
Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform
Press Releases
News Placeholder
Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform
Press Releases
News Placeholder
Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound
Press Releases
News Placeholder
Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner
Press Releases
News Placeholder
Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market
Press Releases
News Placeholder
Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities
Press Releases
<
1
2
...
>

Advertisement|Remove ads.